Clinical Trials Directory

Trials / Completed

CompletedNCT04957498

Feasibility Study Comparing Standard FBT and Guided Self-Help FBT for Adolescent Anorexia Nervosa

Feasibility of Conducting a Randomized Controlled Trial Comparing Standard FBT and Guided Self-Help FBT for Adolescent Anorexia Nervosa

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This study examines a parent only Guided Self-Help for Family Based Treatment (GSH-FBT) for adolescents between the ages of 12 and 18 diagnosed with Anorexia Nervosa. Preliminary data collected in a previous study suggest that a Guided Parental Self-Help Version of FBT (GSH-FBT) has similar outcomes as therapist provided FBT.

Detailed description

In this study, families will be randomized to either receive 12 weekly online sessions of Guided Self-Help for Family Based Treatment (GSH-FBT), or 15 sessions of online, professionally delivered, standard FBT over the course of 6 months. Potential subjects will be recruited from Stanford University, McMaster University, other local medical programs and clinics, and online advertisement to the population at large. If participants are deemed eligible, participants will be invited for a baseline interview during which the investigators will conduct interviews and collect questionnaire measures. Participants will complete a follow-up interview at the end of treatment and 3-month after end of treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGuided Self-Help for Family Based TreatmentA online website provided to parents containing information learned in Family Based Treatment and up to 12 coaching sessions with a therapist.
BEHAVIORALFamily Based TreatmentStandard Family Based Treatment provided for up to 15 sessions.

Timeline

Start date
2019-08-01
Primary completion
2021-06-18
Completion
2021-08-31
First posted
2021-07-12
Last updated
2022-06-06
Results posted
2021-12-13

Locations

2 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT04957498. Inclusion in this directory is not an endorsement.